Discharge and unscheduled readmissions of adult patients undergoing hematopoietic stem cell transplantation: implications for developing nursing interventions
- PMID: 15660137
- DOI: 10.1188/05.onf.e1-e8
Discharge and unscheduled readmissions of adult patients undergoing hematopoietic stem cell transplantation: implications for developing nursing interventions
Abstract
Purpose/objectives: To describe discharge and unscheduled readmission patterns of adult patients undergoing hematopoietic stem cell transplantation (HSCT). To identify implications for nursing practice from survey results and the literature that may improve patient outcomes during and following initial hospital discharge.
Design: Retrospective chart review and literature review.
Setting: National Cancer Institute-designated Comprehensive Cancer Center.
Sample: 100 adult patients undergoing HSCT in the first six months of 2000.
Methods: Investigator-created retrospective chart-review tool collected data in three areas: demographic, clinical, and readmissions in the first six months after discharge.
Main research variables: Demographic variables: gender, marital status, age, and diagnosis; clinical variables: remission status at transplant, type of transplant, presence of comorbid or concurrent conditions, number of infections, number of catheter-related infections, number of bacteremic episodes, and psychosocial support; readmission variables: reason for admission, discharge or death data, number of days of each admission, and length of time between discharge to the next admission.
Findings: Fifty-one percent had at least one unscheduled readmission, and 80% developed an infection after HSCT. Further analysis comparing autologous to allogeneic transplant recipients indicated that the allogeneic group had a higher number of readmissions, unscheduled readmissions, and infections. Patients who reported an infection within a month prior to HSCT had a 50% mortality rate after transplantation.
Conclusions: Findings indicate that allogeneic transplant recipients are a more vulnerable population in regard to infections and readmissions. Developing and testing nursing interventions surrounding the discharge period are needed next steps in improving care.
Implications for nursing: Knowledge of trends in this vulnerable population will guide nursing to plan targeted interventions.
Similar articles
-
Hematopoietic Stem Cell Transplantation Recipient and Caregiver Factors Affecting Length of Stay and Readmission.Oncol Nurs Forum. 2017 Sep 1;44(5):571-579. doi: 10.1188/17.ONF.571-579. Oncol Nurs Forum. 2017. PMID: 28820507
-
Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young Adults.J Pediatr Hematol Oncol. 2017 Nov;39(8):609-613. doi: 10.1097/MPH.0000000000000898. J Pediatr Hematol Oncol. 2017. PMID: 28859043
-
Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survival.Biol Blood Marrow Transplant. 2015 Mar;21(3):509-16. doi: 10.1016/j.bbmt.2014.11.682. Epub 2014 Dec 5. Biol Blood Marrow Transplant. 2015. PMID: 25482866
-
Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12669. Epub 2017 Mar 31. Transpl Infect Dis. 2017. PMID: 28128496 Review.
-
Self-care guidelines for patients in the post-hematopoietic stem cell transplantation period: a scoping review.Rev Bras Enferm. 2023 Oct 9;76(4):e20220383. doi: 10.1590/0034-7167-2022-0383. eCollection 2023. Rev Bras Enferm. 2023. PMID: 37820135 Free PMC article.
Cited by
-
Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantation.Biol Blood Marrow Transplant. 2014 Mar;20(3):415-20. doi: 10.1016/j.bbmt.2013.12.559. Epub 2013 Dec 18. Biol Blood Marrow Transplant. 2014. PMID: 24361913 Free PMC article.
-
Symptom prevalence and physiologic biomarkers among adolescents using a mobile phone intervention following hematopoietic stem cell transplantation.Oncol Nurs Forum. 2014 May;41(3):229-36. doi: 10.1188/14.ONF.229-236. Oncol Nurs Forum. 2014. PMID: 24769589 Free PMC article.
-
Discharge needs of allogeneic transplantation recipients.Clin J Oncol Nurs. 2012 Aug;16(4):E142-9. doi: 10.1188/12.CJON.E142-E149. Clin J Oncol Nurs. 2012. PMID: 22842699 Free PMC article.
-
Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: a comparison of sociodemographic, disease, and treatment characteristics.Support Care Cancer. 2012 Nov;20(11):2697-704. doi: 10.1007/s00520-012-1389-8. Epub 2012 Feb 9. Support Care Cancer. 2012. PMID: 22318502 Free PMC article.
-
Hematopoietic stem cell transplantation dilemma during the COVID-19 era.Future Oncol. 2020 Aug;16(22):1569-1573. doi: 10.2217/fon-2020-0414. Epub 2020 May 27. Future Oncol. 2020. PMID: 32458703 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources